An undated version is under review. The figures below are from the current listed document.

Drugs and doses29

A–C Acetaminophen, Adenosine, Albuterol, Albuterol-Ipratropium, Aspirin, Atropine, Calcium Gluconate, Cefazolin8

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	650–975 mg	PO	not captured	standing	page 432
Other	peds	15 mg/kg	PO	not captured	standing	page 432
Mild to moderate pain	adult	650–975 mg	PO	not captured	standing	page 432
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	page 432

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	page 433
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 433

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	5 mg	NEB	not captured	standing	page 434
Asthma / bronchospasm	peds	2.5–5 mg	NEB	not captured	standing	page 434
Hyperkalemia	adult	10 mg	NEB	not captured	standing	page 305
Hyperkalemia	peds	5 mg	NEB	not captured	standing	page 305

Albuterol-Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	6 mL	NEB	not captured	standing	page 435
Asthma / bronchospasm	peds	3–6 mL	NEB	not captured	standing	page 435

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 436
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 436

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5–1 mg	IV	not captured	standing	page 437
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	page 437
Nerve agent exposure	adult	2–6 mg	IV	not captured	standing	page 437
Nerve agent exposure	peds	0.02 mg/kg	IV	not captured	standing	page 437
Organophosphate poisoning	adult	2–6 mg	IV	not captured	standing	page 437
Organophosphate poisoning	peds	0.02 mg/kg	IV	not captured	standing	page 437

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 g	IV	not captured	standing	page 438
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV	not captured	standing	page 438
Hyperkalemia	adult	2 g	IV	not captured	standing	page 438
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 438
Other	adult	2 g	IV	not captured	standing	page 438
Other	adult	2 g	IV	not captured	standing	page 438
Other	adult	2 g	IV	not captured	standing	page 438
Other	peds	20 mg/kg	IV	not captured	standing	page 438
Other	peds	20 mg/kg	IV	not captured	standing	page 438
Other	peds	20 mg/kg	IV	not captured	standing	page 438

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–3 g	IV	not captured	standing	pages 169, 236, 272, 332, 344, 355

D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Fentanyl7

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	16 mg	IV/IM/PO	not captured	standing	pages 161, 178, 440
Other	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	pages 161, 178, 440

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	pages 158, 225, 447
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	pages 158, 225, 447

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15 mg	IV	not captured	standing	pages 249, 441

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 290, 442
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 290, 442
Other	adult	25–50 mg	PO	not captured	standing	pages 161, 442
Other	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 161, 442
Other	peds	1 mg/kg	PO	not captured	standing	pages 161, 442
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 161, 442

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	0.625–1.25 mg	IV/IM	not captured	standing	pages 158, 272, 302, 443
Nausea / vomiting	peds	0.01 mg/kg	IV/IM	not captured	standing	pages 158, 272, 302, 443
Other	adult	2.5–5 mg	IM	not captured	standing	pages 153, 290, 443

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 161, 444
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 161, 444
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 176, 444
Asthma / bronchospasm	peds	0.15 mg	IM	not captured	standing	pages 176, 444
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 211, 250, 444
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 203, 205, 206, 207, 444
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 203, 205, 206, 207, 444

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.5–1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 138, 147, 158, 164, 166, 167, 169, 172, 179, 184, 189, 194, 195, 217, 236, 241, 242, 246, 248, 249, 252, 300, 326, 332, 337, 342, 344, 345, 354, 355, 357, 445
Mild to moderate pain	peds	0.5–1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 138, 147, 158, 164, 166, 167, 169, 172, 179, 184, 189, 194, 195, 217, 236, 241, 242, 246, 248, 249, 252, 300, 326, 332, 337, 342, 344, 345, 354, 355, 357, 445

G–L Glucagon, Hydrocortisone, Ibuprofen, Labetalol, Lidocaine5

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV	not captured	standing	page 277
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV	not captured	standing	page 277
Beta-blocker / calcium-channel-blocker overdose	peds	0.05 mg/kg	IV	not captured	standing	page 277
Beta-blocker / calcium-channel-blocker overdose	peds	0.05 mg/kg	IV	not captured	standing	page 277
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 158, 225, 446
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 158, 225, 446

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	page 309
Adrenal crisis	peds	25 mg	IV/IO/IM	not captured	standing	page 309

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	400–800 mg	PO	not captured	standing	page 301
Fever	peds	10 mg/kg	PO	not captured	standing	page 301
Mild to moderate pain	adult	400–800 mg	PO	not captured	standing	pages 139, 448
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 139, 448

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	20 mg	IV	not captured	standing	pages 283, 449
Eclampsia / pre-eclampsia	adult	20 mg	IV	not captured	standing	pages 283, 449
Other	adult	20 mg	IV	not captured	standing	pages 306, 449

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	0.75–1.5 mg/kg	IV/IO	not captured	standing	pages 242, 450
Cardiac arrest	peds	1 mg/kg	IV/IO	not captured	standing	pages 242, 450
Other	adult	0.75–1.5 mg/kg	IV	not captured	standing	pages 242, 450
Other	adult	20–40 mg	IO	not captured	standing	pages 400, 450
Other	peds	0.5 mg/kg	IO	not captured	standing	pages 400, 450
Other	peds	1 mg/kg	IV	not captured	standing	pages 242, 450

M–O Magnesium Sulfate, Midazolam, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oxytocin7

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1–2 g	IV	not captured	standing	pages 176, 451
Asthma / bronchospasm	peds	25–50 mg/kg	IV	not captured	standing	pages 176, 451
Eclampsia / pre-eclampsia	adult	4 g	IV	not captured	standing	pages 283, 451
Eclampsia / pre-eclampsia	adult	4 g	IV	not captured	standing	pages 283, 451
Other	adult	2 g	IV/IO	not captured	standing	pages 203, 204, 451
Other	peds	50 mg/kg	IV/IO	not captured	standing	pages 203, 204, 451
Wide-complex tachycardia	adult	2 g	IV/IO	not captured	standing	pages 203, 451
Wide-complex tachycardia	peds	50 mg/kg	IV/IO	not captured	standing	pages 203, 451
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	pages 203, 451
VF / pulseless VT	peds	50 mg/kg	IV/IO	not captured	standing	pages 203, 451

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IN	not captured	standing	page 290
Agitation	adult	2.5–5 mg	IV/IM	not captured	standing	page 290
Agitation	peds	0.1–0.2 mg/kg	IV/IM	not captured	standing	page 290
Agitation	peds	0.1–0.2 mg/kg	IN	not captured	standing	page 290
Eclampsia / pre-eclampsia	adult	10 mg	IM/IN	not captured	standing	page 283
Procedural sedation	adult	2–2.5 mg	IV/IO/IM/IN	not captured	standing	page 15
Seizure	adult	10 mg	IM/IN	not captured	standing	pages 221, 452
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 221, 452

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IN	not captured	standing	page 453
Opioid overdose	adult	0.4–2 mg	IV/IO	not captured	standing	page 453

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 241, 242, 454
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 177, 454
Other	adult	0.4 mg	SL	not captured	standing	page 454

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	2–10 mcg	IV/IO	not captured	standing	pages 307, 456
Hypotension / shock	adult	2–10 mcg	IV/IO	not captured	standing	pages 142, 456
Hypotension / shock	adult	2–10 mcg	IV/IO	not captured	standing	pages 307, 456

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4–8 mg	IV/IM/PO	not captured	standing	pages 158, 457
Nausea / vomiting	adult	4–8 mg	IV/IM/PO	not captured	standing	pages 158, 457
Nausea / vomiting	peds	0.15 mg/kg	IV/IM/PO	not captured	standing	pages 158, 457
Nausea / vomiting	peds	0.15 mg/kg	IV/IM/PO	not captured	standing	pages 158, 457

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 unit	IM	not captured	standing	pages 280, 459

S–Z Sodium Bicarbonate, Sodium Thiosulfate2

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	pages 205, 207, 253, 460
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 205, 207, 253, 460
Other	adult	50 mEq	IV/IO	not captured	standing	pages 203, 205, 206, 460
Other	adult	50 mEq	IV/IO	not captured	standing	pages 341, 342, 460
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 203, 205, 206, 460
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 341, 342, 460
Tricyclic overdose	adult	50–100 mEq	IV/IO	not captured	standing	pages 205, 277, 460
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	pages 205, 277, 460

Sodium Thiosulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	12.5 g	IV	not captured	standing	pages 148, 189, 193, 461
Cyanide poisoning	peds	250 mg/kg	IV	not captured	standing	pages 148, 189, 193, 461

The census is free and not for sale. Only public agencies are named.